Scarica l'app Stockscreener
14.33
1.85%
-0.27
Dopo l'orario di chiusura:
14.05
-0.28
-1.95%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Avalo Therapeutics advances long‑acting IL‑1β candidate AVTX-010, IND planned for 1H 2027 - TradingView
Avalo Therapeutics plans IND submission for AVTX-010 in H1 2027 - Investing.com Canada
Avalo develops longer-lasting antibody to enable less frequent dosing - Stock Titan
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody - GlobeNewswire
Avalo Therapeutics stock soars after positive LOTUS trial results - MSN
AVTX Initiates Coverage On B of A Securities -- Rating Set to Bu - GuruFocus
Avalo Therapeutics amends preferred stock terms and executive agreements - Investing.com
Avalo Therapeutics Expands Ownership Limits, Updates Executive Contracts - TipRanks
Avalo Therapeutics (AVTX) CSO logs 588-share tax-withholding transaction - Stock Titan
Avalo Therapeutics (AVTX) CLO logs tax-withholding of 1,081 shares on Form 4 - Stock Titan
Avalo Therapeutics (NASDAQ: AVTX) CFO logs tax-withholding share move - Stock Titan
[Form 4] Avalo Therapeutics, Inc. Insider Trading Activity - Stock Titan
Avalo Therapeutics (NASDAQ: AVTX) creates Series C-1 preferred and enhances executive change-in-control pay - Stock Titan
BofA Securities Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $35 - Moomoo
This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BofA initiates Avalo Therapeutics stock with buy rating on HS drug - Investing.com Nigeria
FMR LLC's Strategic Acquisition of Avalo Therapeutics Inc Shares - GuruFocus
AVALO THERAPEUTICS INC (AVTX) Stock Chart - ChartMill
Avalo Therapeutics: Sell-Off Could Continue If Overall Market Deteriorates Further - Seeking Alpha
Avalo Therapeutics elects directors, approves stock plan and auditor at annual meeting - Investing.com UK
Avalo Therapeutics (AVTX) holders approve ESPP, elect 7 directors and ratify Ernst & Young - Stock Titan
Avalo Therapeutics prices $375 million stock offering By Investing.com - Investing.com Nigeria
FMR LLC amendment shows 3.19M shares in Avalo Therapeutics (AVTX) - Stock Titan
Deep Track Capital, LP Acquires Significant Stake in Avalo Thera - GuruFocus
Deep Track Capital, LP Acquires Significant Stake in Avalo Therapeutics Inc - GuruFocus
Director at Avalo Therapeutics (AVTX) granted 20,100 stock options - Stock Titan
Avalo Therapeutics (AVTX) director receives grant of 20,100 stock options at $13.96 - Stock Titan
Avalo Therapeutics (AVTX) director receives 20,100 stock options at $13.96 strike - Stock Titan
Avalo Therapeutics (AVTX) director receives stock options for 20,100 shares - Stock Titan
Avalo Therapeutics (AVTX) director awarded 29,500 options at $13.96 strike - Stock Titan
Avalo Therapeutics (AVTX) director granted 20,100 stock options at $13.96 strike - Stock Titan
Avalo Therapeutics (AVTX) Edges Higher as Stock Tests Key Near-Term ResistanceBPI Bear Correction - newsline.com
AVTX: Broker-listed notice for proposed sales of 43,?33 shares (06/02/2026) - Stock Titan
Avalo Therapeutics (AVTX) CMO sells shares under 10b5-1 plan - Stock Titan
AVTX Q1 2026 Earnings: Narrower Loss Lifts Investor Sentiment Amid Continued Pre-Revenue StageOperating Margin Analysis - newsline.com
Deep Track holds 5.81% of Avalo Therapeutics (AVTX) in Schedule 13G filing - Stock Titan
AVTX News | AVALO THERAPEUTICS INC (NASDAQ:AVTX) - ChartMill
Avalo Therapeutics (AVTX) Stock Price, Quote, Charts & News - Invezz
Point72 (AVTX) reports 2.71M-share, 5.2% position in Avalo Therapeutics - Stock Titan
Avalo Therapeutics (AVTX) CSO granted 34,200 performance stock units vesting in 2028 - Stock Titan
Avalo Therapeutics (AVTX) CFO receives 39,900 PSU-linked shares in equity award - Stock Titan
Avalo Therapeutics (AVTX) CLO granted 24,300 performance-based common shares - Stock Titan
Avalo Therapeutics (AVTX) CMO receives 43,500-share performance award - Stock Titan
Performance stock units expand Avalo (NASDAQ: AVTX) CEO’s stake - Stock Titan
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Avalo Therapeutics (AVTX) Holds Steady Near Key Support LevelsRetail Driven Moves - newsline.com
AVTX Q1 2026 Earnings: Narrower-Than-Expected Loss Marks a Slight Positive SurpriseOne-Time Loss Impact - newsline.com
Avalo Therapeutics (AVTX) CMO exercises options and sells 3,000 shares under plan - Stock Titan
Avalo Therapeutics (AVTX) price target increased by 18.49% to 47.94 - MSN
UBS Group AG Has $8.68 Million Stock Position in Avalo Therapeutics, Inc. $AVTX - MarketBeat
Avalo Therapeutics Urges Investors to Heed Form 10-Q Risk Factors Amid Ongoing Uncertainty - TipRanks
Wolfe Research initiates coverage of Avalo Therapeutics (AVTX) with outperform recommendation - MSN
Logos Global (AVTX) discloses 1.675M-share position, 3.2% of stock - Stock Titan
RA Capital and principals report 9.99% stake in Avalo Therapeutics (AVTX) - Stock Titan
OrbiMed reports 475,165 Avalo Therapeutics shares (AVTX) at 2.1% - Stock Titan
BVF affiliates report ~2.35M AVTX shares (NYSE: AVTX) under group attribution - Stock Titan
A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $55 - Moomoo
Caligan Partners and David Johnson report 7.2% stake in Avalo (AVTX) - Stock Titan
T. Rowe Price (AVTX) shows 2.16M shares, 9.5% of Avalo Therapeutics - Stock Titan
Avoro holds 1.41M shares in Avalo Therapeutics (NASDAQ: AVTX) - Stock Titan
These Analysts Revise Their Forecasts On Avalo Therapeutics After Q1 Results - Sahm
Apple To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):